Bryan Irving
2018
Compensation breakdown
Non-Equity Incentive Plan | $135,580 |
---|---|
Option Awards | $671,379 |
Salary | $383,489 |
Stock Awards | $178,703 |
Other | $6,072 |
Total | $1,375,223 |
Irving received $671.4K in option awards, accounting for 49% of the total pay in 2018.
Irving also received $135.6K in non-equity incentive plan, $383.5K in salary, $178.7K in stock awards and $6.1K in other compensation.
Rankings
In 2018, Bryan Irving's compensation ranked 7,588th out of 14,244 executives tracked by ExecPay. In other words, Irving earned more than 46.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,588 | 47th |
Manufacturing | 2,948 | 49th |
Chemicals And Allied Products | 1,106 | 48th |
Drugs | 936 | 49th |
Pharmaceutical Preparations | 732 | 47th |
Pay ratio
Bryan Irving's Pay | $1,375,223 |
---|---|
Median Employee's Pay | $201,670 |
Pay Ratio | 7to 1 |
In 2018, the annual total compensation of Bryan Irving was $1,375,223.
The annual total compensation of the median employee at Five Prime Therapeutics was $201,670.
The ratio of Bryan Irving's pay to the pay of median employee was therefore 7 to one.
Irving's colleagues
We found six more compensation records of executives who worked with Bryan Irving at Five Prime Therapeutics in 2018.
2018
Aron Knickerbocker
Five Prime Therapeutics
Chief Executive Officer
2018
David Smith
Five Prime Therapeutics
Chief Financial Officer
2018
Helen Collins
Five Prime Therapeutics
Chief Medical Officer
2018
Francis Sarena
Five Prime Therapeutics
Secretary
2018
Linda Rubinstein
Five Prime Therapeutics
Chief Financial Officer
2018
Marc Belsky
Five Prime Therapeutics